EEF1A2 and cancer: Altered expression or mutation of key enzymes involved in O-glycan biosynthesis, such as core1-specific-molecular-chaperone (COSMC), core1 β3-galactosyltransferase (T synthase), and ST6GalNAc1, leads to the overexpression of sTn in cancer and other pathological conditions [8].